461 related articles for article (PubMed ID: 18771432)
1. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
Ormerod AS; Cook MC
Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
Gibson A; Stamp LK; Chapman PT; O'Donnell JL
Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.
Mohammad AJ; Jacobsson LT; Mahr AD; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2007 Aug; 46(8):1329-37. PubMed ID: 17553910
[TBL] [Abstract][Full Text] [Related]
5. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
[TBL] [Abstract][Full Text] [Related]
6. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
[TBL] [Abstract][Full Text] [Related]
8. Primary systemic vasculitis: clinical features and mortality.
Lane SE; Watts RA; Shepstone L; Scott DG
QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
[TBL] [Abstract][Full Text] [Related]
9. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.
Allenbach Y; Seror R; Pagnoux C; Teixeira L; Guilpain P; Guillevin L;
Ann Rheum Dis; 2009 Apr; 68(4):564-7. PubMed ID: 19015208
[TBL] [Abstract][Full Text] [Related]
10. Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.
Chanseaud Y; Tamby MC; Guilpain P; Reinbolt J; Kambouchner M; Boyer N; Noël LH; Guillevin L; Boissier MC; Mouthon L
J Autoimmun; 2005 Mar; 24(2):169-79. PubMed ID: 15829409
[TBL] [Abstract][Full Text] [Related]
11. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
Gross WL; Reinhold-Keller E
Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
[TBL] [Abstract][Full Text] [Related]
12. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].
Bolley R; Mistry-Burchardi N; Samtleben W
Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761
[TBL] [Abstract][Full Text] [Related]
13. Wegener's granulomatosis: epidemiological and clinical features in a South Australian study.
Hissaria P; Cai FZ; Ahern M; Smith M; Gillis D; Roberts-Thomson P
Intern Med J; 2008 Oct; 38(10):776-80. PubMed ID: 19143878
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
[TBL] [Abstract][Full Text] [Related]
15. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides.
Mavrogeni S; Manoussakis MN; Karagiorga TC; Douskou M; Panagiotakos D; Bournia V; Cokkinos DV; Moutsopoulos HM
Arthritis Rheum; 2009 Aug; 61(8):1121-9. PubMed ID: 19644909
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement.
Gibelin A; Maldini C; Mahr A
Semin Respir Crit Care Med; 2011 Jun; 32(3):264-73. PubMed ID: 21674413
[TBL] [Abstract][Full Text] [Related]
17. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a Childhood Arthritis and Rheumatology Alliance (CARRA) survey.
Wilkinson NM; Page J; Uribe AG; Espinosa V; Cabral DA
J Rheumatol; 2007 Jan; 34(1):224-6. PubMed ID: 17117484
[TBL] [Abstract][Full Text] [Related]
19. The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI).
Mohammad AJ; Bakoush O; Sturfelt G; Segelmark M
Scand J Rheumatol; 2009; 38(4):268-75. PubMed ID: 19296401
[TBL] [Abstract][Full Text] [Related]
20. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
Tidman M; Olander R; Svalander C; Danielsson D
J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
